[EN] PEPTIDYLARGININE DEIMINASES (PAD) INHIBITORS<br/>[FR] INHIBITEURS DE PEPTIDYLARGININE DÉIMINASES (PAD)
申请人:UCL BUSINESS PLC
公开号:WO2014188193A1
公开(公告)日:2014-11-27
The present invention relates to compounds of the formula (I): as inhibitors of peptidylarginine deiminases (PADs). It also concerns their use in therapy, particularly in the prophylaxis or treatment of neural injury, and other conditions including cancer, multiple sclerosis, glaucoma, arthritis, rheumatoid arthritis lupus, Alzheimer's disease, and ulcerative colitis.